A retrospective study identified prognostic factors for long survival — 20+ years — in patients with primary myelofibrosis.
A survey-based study investigated the relationship between symptom burden and incidence of medical disability leave among patients with MPNs.
Researchers sought to determine the prevalence and severity of anxiety and/or depression among patients with Philadelphia-negative MPNs.
A study with more than 2000 patient-years follow-up, researchers found cytoreductive therapy was not as effective in patients with ET who have lower risk for thrombosis.
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients.